期刊文献+

激动κ阿片受体对大鼠高原性肺水肿的预防效果 被引量:2

Efficacy of acting κ opioid receptor for prevention of high altitude pulmonary edema in rats
原文传递
导出
摘要 目的 评价激动κ阿片受体对大鼠高原性肺水肿的预防效果.方法 雄性SD大鼠40只,8周龄,体重250 ~ 300 g,采用随机数字表法,将其分为5组(n=8):对照组(C组)、低压低氧组(H组)、生理盐水+低压低氧组(NH组)、κ阿片受体激动剂U50488H+低压低氧组(UH组)、选择性κ阿片受体拮抗剂nor-BNI+U50488H+低压低氧组(NUH组).大鼠置于低压低氧舱(大气压355 mmHg,氧分压74 mmHg)2 d以制备高原性肺水肿模型.模型制备前3d,NH组腹腔注射生理盐水0.5 ml,UH组腹腔注射U50488H 1.25 mg/kg,NUH组腹腔注射nor-BNI 2.0 mg/kg,10 min后腹腔注射U50488H 1.25mg/kg,均为每日1次.低压低氧处理2d后,测定平均肺动脉压(mPAP),取动脉血样,测定血清丙二醛(MDA)和促红细胞生成素(EPO)的水平;随后处死大鼠,取肺组织,计算肺含水量,测定肺组织一氧化氮(NO)、诱导型一氧化氮合酶(iNOS)、MDA、SOD、内皮素-1(ET-1)、血栓素B2 (TXB2)和6-酮-前列腺素F1α(6-keto-PGF1α)的水平,并计算TXB2/6-keto-PGF1α比值.光镜下观察肺组织病理学结果.结果 与C组比较,其余4组大鼠mPAP、肺含水量、肺组织ET-1、MDA、TXB2和6-keto-PGF1α水平、TXB2/6-keto-PGF1α比值和血清MDA和EPO水平升高,肺组织iNOS、NO、SOD水平降低(P<0.05);与H组比较,UH组大鼠mPAP、肺含水量、肺组织ET-1、MDA、TXB2和6-keto-PGF1α水平、TXB2/6-keto-PGF1α比值和血清MDA和EPO水平降低,肺组织iNOS、NO、SOD水平升高(P<0.05),NH组和NUH组上述指标差异无统计学意义(P>0.05).UH组肺组织病理损伤较H组减轻.结论 激动κ阿片受体可对大鼠高原性肺水肿产生预防效果,机制与抑制脂质过氧化反应和纠正缩血管/舒张血管因子失衡有关. Objective To evaluate the efficacy of acting κ opioid receptor for prevention of high altitude pulmonary edema (HAPE) in rats.Methods Forty male Sprague-Dawley rats,aged 8 weeks,weighing 250-300 g,were randomly divided into 5 groups (n =8 each) using a random number table:control group (group C),hypobaric hypoxia group (group H),normal saline + hypobaric hypoxia group (group NH),U50488H (a selective kappa-opioid receptor agonist) + hypobaric hypoxia group (group UH),and nor-binaltorphimine (norBNI,a selective kappa-opioid receptor antagonist) + U50488H + hypobaric hypoxia group (group NUH).The rats were put into the hyperbaric chamber and exposed to hypobaric hypoxia (atmospheric pressure 355 mmHg,partial pressure of oxygen 74 mmHg) for 2 days to induce HAPE.At 3 days before HAPE,normal saline 0.5 ml,U50488H 1.25 mg/kg,and nor-BNI 2.0 mg/kg were injected intraperitoneally once a day in NH,UH,and NUH groups,respectively,and in addition U50488H 1.25 mg/kg was injected intraperitoneally 10 min later in NUH group.After 2 h exposure to hypobaric hypoxia,mean pulmonary artery pressure (mPAP) was detected,and arterial blood samples were collected for determination of serum malondialdehyde (MDA) and erythropoietin (EPO) levels.The rats were then sacrificed and lungs were removed for microscopic examination and for determination of the levels of nitric oxide (NO),inducible nitric oxide synthase (iNOS),MDA,superoxide dismutase (SOD),endothelin-1 (ET-1),thromboxane B2 (TXB2),and 6-keto-prostaglandin F1α (6-keto-PGF1α) in lung tissues.Lung water content and TXB2/6-keto-PGF1α ratio was calculated.Results Compared with group C,mPAP,lung water content,ET-1,MDA,TXB2 and 6-keto-PGF1α levels,TXB2/6-ketoPGF1α ratio,and serum MDA and EPO levels were significantly increased,and iNOS,NO and SOD levels were decreased in the other four groups (P 〈 0.05).Compared with group H,mPAP,lung water content,ET-1,MDA,TXB2 and 6-keto-PGF1α levels,TXB2/6-ketoPGF1α ratio and serum MDA and EPO levels were significantly decreased,and iNOS,NO and SOD levels were increased in UH group (P 〈 0.05),and no significant changes were found in the indexes mentioned above in NH and NUH groups (P 〉 0.05).The pathological changes of lung tissues were significantly attenuated in group UH as compared with H group.Conclusion Acting κ opioid receptor can produce prevention for HAPE in rats,and inhibition of lipid peroxidation and correction of the imbalance between vasoconstrictive factors and vasodilative factors may be involved in the mechanism.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2014年第1期108-111,共4页 Chinese Journal of Anesthesiology
关键词 受体 阿片类 κ 肺水肿 高原病 Receptors,opioid,kappa Pulmonary edema Altitude sickness
  • 相关文献

参考文献14

  • 1Stream JO, Grissom CK. Update on high-altitude pulmonary edema: pathogenesis, prevention, and treatment [J]. Wilderness Environ Med, 2008,19(4) :293-303.
  • 2王桂芳,白春学,李素芝.高原性肺水肿发病机制的研究进展[J].中国呼吸与危重监护杂志,2008,7(4):318-320. 被引量:9
  • 3Maggiorini M. Prevention and treatment of high-altitude pulmonary edema[J]. Prog Cardiovasc Dis, 2010, 52(6) :500-506.
  • 4Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension [ J ]. Pharmacol Ther,2001,92(1) : 1-20.
  • 5Pei JM, Sun X, Gun HT, et al. U50488H depresses pulmonary pre- ssure in rats subjected to chronic hypoxia[ J]. Cardiovasc Pharmacol, 2006,47 (4) : 594-598.
  • 6Sun X, Ma S, Zang YM, et al. Vasorelaxing effect of U50488H in pulmonary artery and underlying mechanism in rats [ J ]. Life Sci, 2006,78 (21) : 2516-2522.
  • 7Bai C, She J, Goolaerts A, et al. Stress failure plays a major role in the development of high-altitude pulmonary edema in rats[ J ]. Eur Respir J,2010,35(3) :584-591.
  • 8Berg .IT. Ginkgo biloba extract prevents high altitude pulmonary ede- ma in rats[J]. High Alt Med Biol, 2004,5(4):429-434.
  • 9Engebretsen B J, Irwin D, Valdez ME, et al. Acute hypobaric hyp- oxia (5486 m) induces greater pulmonary HIF-I activation in hilltop compared to madison rats[J]. High Alt Med Biol, 2007,8(4):312- 321.
  • 10张兆瑞,张波,何萍萍,王东.高原肺水肿动物模型的初步建立[J].中国医药导报,2011,8(27):27-28. 被引量:7

二级参考文献31

  • 1陈宏莉,海春旭,梁欣,刘瑞,李嘉琳,王鹏.大鼠光气染毒后不同时间点肺水肿及炎症反应的差异性研究[J].癌变.畸变.突变,2006,18(2):93-95. 被引量:7
  • 2Bartsch P,Mairbaurl H,Maggiorini M,et al.Physiological aspects of high-altitude pulmonary edema[J].J Appl Physiol,2005,98(3):1101-1110.
  • 3Bai C,She J,Goolaerts A,et al.Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats[J].Eur Respir J,2010,35(3):584-591.
  • 4Kleinsasser A,Levin DL,Loeckinger A,et al.A pig model of high altitude pulmonary edema[J].High Alt Med Biol,2003,4(4):465-474.
  • 5Berg JT.Ginkgo biloba extract prevents high altitude pulmonary edema in rats[J].High Alt Med Biol,2004,5(4):429-434.
  • 6Duplain H,Sartori C,Lepori M,et al.Exhaled nitric oxide in high-altitude pulmonary edema:role in the regulation of pulmonary vascular tone and evidence for a role against inflammation[J].Am J Respir Crit Care Med,2000,162(1):221-224.
  • 7Droma Y,Hayano T,Takabayashi Y,et al.Endothelin-1 and interleukin-8 in high altitude pulmonary oedema[J].Eur Respir J,1996,9(9):1947-1949.
  • 8Yamashita K, Discher DJ, Hu J, et al. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem,2001,276 : 12645-12653.
  • 9Carpenter TC, Schomberg S, Stenmark KR. Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia. Am J Physiol Lung Cell Mol Physiol, 2005,289: L1075- 1082.
  • 10Modesti PA, Vanni S, Morabito M, et al. Role of endothelin- 1 in exposure to high altitude:Acute Mountain Sickness and Endothelin-1 ( ACME-1 ) study. Circulation, 2006, 114: 1410-1416.

共引文献14

同被引文献15

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部